相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Local myostatin inhibition improves skeletal muscle glucose uptake in insulin-resistant high-fat diet-fed mice
Wouter Eilers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes
Amy M. Nicks et al.
SCIENTIFIC REPORTS (2020)
Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk
Jiao Wu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis
Hong-Kun Wu et al.
CIRCULATION (2019)
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease
Daniela Verzola et al.
KIDNEY INTERNATIONAL (2019)
Evolving concepts in the pathogenesis of uraemic cardiomyopathy
Xiaoliang Wang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Y Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk
Jiao Wu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Katherine R. Tuttle et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys
Hui Peng et al.
NATURE COMMUNICATIONS (2017)
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Guanghong Jia et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer
Serkan Kir et al.
CELL METABOLISM (2016)
Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
Marcello Tonelli et al.
CIRCULATION (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cleavage of Signal Regulatory Protein α (SIRPα) Enhances Inflammatory Signaling
James D. Londino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Prolonged Cre expression driven by the α-myosin heavy chain promoter can be cardiotoxic
Emily K. Pugach et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study
Julia Aliz Baan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
p-Cresyl Sulfate Aggravates Cardiac Dysfunction Associated With Chronic Kidney Disease by Enhancing Apoptosis of Cardiomyocytes
Hui Han et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Association of Sarcopenia with eGFR and Misclassification of Obesity in Adults with CKD in the United States
Deep Sharma et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
New insights into IGF-1 signaling in the heart
Rodrigo Troncoso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD
Laetitia Koppe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease
Sandhya S. Thomas et al.
KIDNEY INTERNATIONAL (2013)
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Bente K. Pedersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
A conditional knockout resource for the genome-wide study of mouse gene function
William C. Skarnes et al.
NATURE (2011)
Return to the fetal gene program A suggested metabolic link to gene expression in the heart
Heinrich Taegtmeyer et al.
ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE (2010)
Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
Karina Huynh et al.
DIABETES (2010)
The GH/IGF-1 Axis and Heart Failure
Graziella Castellano et al.
CURRENT CARDIOLOGY REVIEWS (2009)
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease
Robert H. Mak et al.
GROWTH HORMONE & IGF RESEARCH (2008)
Signal Regulatory Proteins (SIRPS) Are Secreted Presynaptic Organizing Molecules
Hisashi Umemori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide
Begona Lopez et al.
KIDNEY INTERNATIONAL (2008)
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease
D. Charytan et al.
KIDNEY INTERNATIONAL (2006)
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
T Nagoshi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells
Y Ling et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Electrocardiographic abnormalities and uremic cardiomyopathy
GA Stewart et al.
KIDNEY INTERNATIONAL (2005)
Model of robust induction of glomerulosclerosis in mice: Importance of genetic background
LJ Ma et al.
KIDNEY INTERNATIONAL (2003)
The syndrome of cardiac cachexia
SD Anker et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2002)
Induction of cachexia in mice by systemically administered myostatin
TA Zimmers et al.
SCIENCE (2002)
分享论文
